Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Hu

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancerChanghu Chen, Madeleine Kane, John Song, et al.
Cancer Cell|December 15, 2020
Visualizing CancerMatthew Krummel, Kenneth Hu, Elisabeth G E de Vries, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response in squamous cell skin carcinomaMiho Tanaka, Lotus Lum, Kenneth Hu, et al.
The Laryngoscope|January 1, 2008
Feasibility of flap reconstruction in conjunction with intraoperative radiation therapy for advanced and recurrent head and neck cancerMichael D Most, Alexander C Allori, Kenneth Hu, et al.
Head & Neck|April 19, 2020
Tracheostomy during SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck SocietyBrett A Miles, Bradley Schiff, Ian Ganly, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.
Cancers|March 29, 2023
Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United StatesSujith Baliga, Vedat O Yildiz, Jose Bazan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 26, 2026
Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancerKenneth Hu, Pratish Shah, M Connie Nguyen, et al.
Cell Host & Microbe|June 15, 2011
Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammationKirk D C Jensen, Yiding Wang, Elia D Tait Wojno, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancerChanghu Chen, Madeleine Kane, John Song, et al.
Cancer Cell|December 15, 2020
Visualizing CancerMatthew Krummel, Kenneth Hu, Elisabeth G E de Vries, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response in squamous cell skin carcinomaMiho Tanaka, Lotus Lum, Kenneth Hu, et al.
The Laryngoscope|January 1, 2008
Feasibility of flap reconstruction in conjunction with intraoperative radiation therapy for advanced and recurrent head and neck cancerMichael D Most, Alexander C Allori, Kenneth Hu, et al.
Head & Neck|April 19, 2020
Tracheostomy during SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck SocietyBrett A Miles, Bradley Schiff, Ian Ganly, et al.
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.
Cancers|March 29, 2023
Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United StatesSujith Baliga, Vedat O Yildiz, Jose Bazan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 26, 2026
Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancerKenneth Hu, Pratish Shah, M Connie Nguyen, et al.
Cell Host & Microbe|June 15, 2011
Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammationKirk D C Jensen, Yiding Wang, Elia D Tait Wojno, et al.
Pageof 6